Sartorius Aktiengesellschaft (0NIQ.L)
EUR 178.4
(1.02%)
EUR 178.4
(1.02%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.03 Billion EUR | -12.08% |
| 2022 | 1.17 Billion EUR | 32.06% |
| 2021 | 892.82 Million EUR | 60.21% |
| 2020 | 557.28 Million EUR | 35.04% |
| 2019 | 412.67 Million EUR | 28.28% |
| 2018 | 321.69 Million EUR | 30.7% |
| 2017 | 246.12 Million EUR | 10.77% |
| 2016 | 222.18 Million EUR | 17.07% |
| 2015 | 189.78 Million EUR | 30.04% |
| 2014 | 145.94 Million EUR | 5.03% |
| 2013 | 138.95 Million EUR | 10.05% |
| 2012 | 126.26 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 868 Million EUR | -7.22% |
| 2024 Q2 | 935.5 Million EUR | -8.97% |
| 2024 Q1 | 1.02 Billion EUR | -0.87% |
| 2023 Q4 | 1.03 Billion EUR | -10.2% |
| 2023 FY | 1.03 Billion EUR | -12.08% |
| 2023 Q1 | 1.21 Billion EUR | 3.19% |
| 2023 Q2 | 1.19 Billion EUR | -1.92% |
| 2023 Q3 | 1.15 Billion EUR | -3.27% |
| 2022 Q3 | 1.21 Billion EUR | 10.94% |
| 2022 Q1 | 978 Million EUR | 9.54% |
| 2022 FY | 1.17 Billion EUR | 32.06% |
| 2022 Q2 | 1.09 Billion EUR | 11.85% |
| 2022 Q4 | 1.17 Billion EUR | -2.84% |
| 2021 Q4 | 892.82 Million EUR | 10.95% |
| 2021 Q2 | 690.7 Million EUR | 0.0% |
| 2021 FY | 892.82 Million EUR | 60.21% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q3 | 804.7 Million EUR | 16.5% |
| 2020 Q4 | 557.28 Million EUR | 4.81% |
| 2020 Q3 | 531.7 Million EUR | 5.54% |
| 2020 FY | 557.28 Million EUR | 35.04% |
| 2020 Q1 | 426.6 Million EUR | 3.37% |
| 2020 Q2 | 503.8 Million EUR | 18.1% |
| 2019 Q3 | 402.2 Million EUR | 8.76% |
| 2019 FY | 412.67 Million EUR | 28.28% |
| 2019 Q4 | 412.67 Million EUR | 2.6% |
| 2019 Q2 | 369.8 Million EUR | 6.39% |
| 2019 Q1 | 347.6 Million EUR | 8.05% |
| 2018 Q2 | 282.3 Million EUR | 5.81% |
| 2018 Q3 | 310.2 Million EUR | 9.88% |
| 2018 Q1 | 266.8 Million EUR | 8.4% |
| 2018 FY | 321.69 Million EUR | 30.7% |
| 2018 Q4 | 321.69 Million EUR | 3.71% |
| 2017 Q2 | 241.9 Million EUR | -0.49% |
| 2017 FY | 246.12 Million EUR | 10.77% |
| 2017 Q4 | 246.12 Million EUR | -0.6% |
| 2017 Q3 | 247.6 Million EUR | 2.36% |
| 2017 Q1 | 243.1 Million EUR | 9.41% |
| 2016 Q1 | 207.2 Million EUR | 9.18% |
| 2016 Q4 | 222.18 Million EUR | -2.16% |
| 2016 Q3 | 227.1 Million EUR | 2.99% |
| 2016 Q2 | 220.5 Million EUR | 6.42% |
| 2016 FY | 222.18 Million EUR | 17.07% |
| 2015 Q1 | 170.7 Million EUR | 16.97% |
| 2015 FY | 189.78 Million EUR | 30.04% |
| 2015 Q4 | 189.78 Million EUR | 4.33% |
| 2015 Q3 | 181.9 Million EUR | 0.17% |
| 2015 Q2 | 181.6 Million EUR | 6.39% |
| 2014 Q2 | 155.8 Million EUR | 6.2% |
| 2014 Q1 | 146.7 Million EUR | 5.57% |
| 2014 FY | 145.94 Million EUR | 5.03% |
| 2014 Q4 | 145.94 Million EUR | -13.75% |
| 2014 Q3 | 169.2 Million EUR | 8.6% |
| 2013 Q1 | 137.6 Million EUR | 8.98% |
| 2013 Q3 | 142.7 Million EUR | 3.03% |
| 2013 Q4 | 138.95 Million EUR | -2.62% |
| 2013 Q2 | 138.5 Million EUR | 0.65% |
| 2013 FY | 138.95 Million EUR | 10.05% |
| 2012 Q4 | 126.26 Million EUR | 0.0% |
| 2012 FY | 126.26 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cegedim SA | 9.2 Million EUR | -11167.254% |
| Guerbet SA | 305.17 Million EUR | -239.703% |
| Nexus AG | 3.22 Million EUR | -32025.813% |
| Bastide Le Confort Médical SA | 43.2 Million EUR | -2299.38% |
| Revenio Group Oyj | 10.5 Million EUR | -9773.333% |
| Drägerwerk AG & Co. KGaA | 657.88 Million EUR | -57.58% |
| LNA Santé SA | 148.29 Million EUR | -599.065% |
| Siemens Healthineers AG | 4.26 Billion EUR | 75.67% |
| Medios AG | 60.43 Million EUR | -1615.34% |
| Equasens Société anonyme | 10.31 Million EUR | -9951.386% |
| Stratec SE | 142.62 Million EUR | -626.871% |